NDC 50090-6247 – Biktarvy
Bictegravir Sodium 50 mg/1; Emtricitabine 200 mg/1; Tenofovir Alafenamide Fumarate 25 mg/1 · Tablet · Oral
Product NDC50090-6247
Product details
- Brand name
- Biktarvy
- Generic name
- Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Labeler
- A-S Medication Solutions
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA210251
- Marketed since
- February 7, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Bictegravir Sodium 50 mg/1
- Emtricitabine 200 mg/1
- Tenofovir Alafenamide Fumarate 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50090-6247-0 | 30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0) | Nov 28, 2022 |
Other Biktarvy products
- 61958-2501 Bictegravir Sodium 50 mg/1; Emtricitabine 200 mg/1; Tenofovir… · Tablet · Gilead Sciences, Inc.
- 61958-2505 Bictegravir Sodium 30 mg/1; Emtricitabine 120 mg/1; Tenofovir… · Tablet · Gilead Sciences, Inc.
- 61958-2506 Bictegravir Sodium 30 mg/1; Emtricitabine 120 mg/1; Tenofovir… · Tablet · Gilead Sciences, Inc.